A report from a round table discussion on the margins of the 72nd World Health Assembly in Geneva, Switzerland.
The document: Assuring Quality In Medicines 0730 Final
Ed Vreeke
Assuring Quality in Medicines Procurement
Rapport d’une table ronde organisée en marge de la 72e Assemblée mondiale de la Santé à Genève, Suisse.
Le document: Assuring Quality In Medicines 0730 Final
Be-cause Health literature updates
REF: Tuck et al. Editorial: Medicines pricing, access and safety in Morocco. Trop Med Int H 2019. doi:10.1111/tmi.13191
2019 TMIH Tuck Editorial Medicines Pricing Access Safety Morocco
Dear Friend,
In case you missed it, I would like to share this recent Editorial from TMIH, which gives an interesting overview of challenges faced by the pharmaceutical sector in Morocco. As summarized in the abstract, “unregulated supply of medicines compromises quality assurance and risks patient safety. The emergence of illegal medicines trafficking in Morocco presents a major health threat, which highlights
the need for region-wide alignment in policies to drive stringent regulatory enforcement and robust health systems that ensure population- wide access to safe medicines”. Even if the analysis concerns a specific lower- middle income setting, the reflection on the links across access and quality assurance is of relevance for any other contexts. Have a nice reading,
Raffaella
Be-cause Health literature updates
REF: Tuck et al. Editorial: Medicines pricing, access and safety in Morocco. Trop Med Int H 2019. doi:10.1111/tmi.13191
2019 TMIH Tuck Editorial Medicines Pricing Access Safety Morocco
Dear Friend,
In case you missed it, I would like to share this recent Editorial from TMIH, which gives an interesting overview of challenges faced by the pharmaceutical sector in Morocco. As summarized in the abstract, “unregulated supply of medicines compromises quality assurance and risks patient safety. The emergence of illegal medicines trafficking in Morocco presents a major health threat, which highlights
the need for region-wide alignment in policies to drive stringent regulatory enforcement and robust health systems that ensure population- wide access to safe medicines”. Even if the analysis concerns a specific lower- middle income setting, the reflection on the links across access and quality assurance is of relevance for any other contexts. Have a nice reading,
Raffaella
